Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0240 Transporter Info | ||||
Gene Name | SLC27A3 | ||||
Transporter Name | Long-chain fatty acid transport protein 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Prostate cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
5'UTR (cg12662091) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 3.76E-02; Z-score: 1.97E+00 | ||
Methylation in Case |
9.53E-02 (Median) | Methylation in Control | 8.04E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
TSS1500 (cg17243364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.28E+00 | Statistic Test | p-value: 9.03E-03; Z-score: -3.15E+00 | ||
Methylation in Case |
1.30E-01 (Median) | Methylation in Control | 1.66E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
TSS1500 (cg13818276) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 3.03E-02; Z-score: 3.35E+00 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 7.27E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
Body (cg19377250) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.52E+00 | Statistic Test | p-value: 1.88E-03; Z-score: 6.25E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 5.41E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in prostate cancer | [ 1 ] | |||
Location |
Body (cg11640015) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 5.34E-03; Z-score: 2.32E+00 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 6.61E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.28E+00 | Statistic Test | p-value: 3.16E-03; Z-score: 2.42E+00 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 5.80E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 2.33E-02; Z-score: 1.08E+00 | ||
Methylation in Case |
6.79E-01 (Median) | Methylation in Control | 6.30E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg05784314) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.37E+00 | Statistic Test | p-value: 2.93E-02; Z-score: 1.62E+00 | ||
Methylation in Case |
4.46E-02 (Median) | Methylation in Control | 3.27E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.69E+00 | Statistic Test | p-value: 3.53E-02; Z-score: -3.27E+00 | ||
Methylation in Case |
1.40E-01 (Median) | Methylation in Control | 2.38E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in bladder cancer | [ 2 ] | |||
Location |
3'UTR (cg11804721) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.29E+00 | Statistic Test | p-value: 5.00E-06; Z-score: -1.21E+01 | ||
Methylation in Case |
4.27E-01 (Median) | Methylation in Control | 5.52E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.62E+00 | Statistic Test | p-value: 7.34E-32; Z-score: 4.88E+00 | ||
Methylation in Case |
6.60E-01 (Median) | Methylation in Control | 4.08E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 2.88E-18; Z-score: 2.54E+00 | ||
Methylation in Case |
8.04E-01 (Median) | Methylation in Control | 6.55E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.56E+00 | Statistic Test | p-value: 8.78E-15; Z-score: 3.13E+00 | ||
Methylation in Case |
6.74E-01 (Median) | Methylation in Control | 4.33E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.68E+00 | Statistic Test | p-value: 1.25E-09; Z-score: 2.90E+00 | ||
Methylation in Case |
2.33E-01 (Median) | Methylation in Control | 1.39E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.43E+00 | Statistic Test | p-value: 1.01E-07; Z-score: 1.46E+00 | ||
Methylation in Case |
1.49E-01 (Median) | Methylation in Control | 1.04E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.68E+00 | Statistic Test | p-value: 1.40E-07; Z-score: 2.30E+00 | ||
Methylation in Case |
2.70E-01 (Median) | Methylation in Control | 1.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.59E+00 | Statistic Test | p-value: 3.10E-06; Z-score: 1.56E+00 | ||
Methylation in Case |
1.50E-01 (Median) | Methylation in Control | 9.43E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.65E+00 | Statistic Test | p-value: 6.24E-06; Z-score: 1.41E+00 | ||
Methylation in Case |
5.43E-02 (Median) | Methylation in Control | 3.28E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg05784314) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.44E+00 | Statistic Test | p-value: 3.42E-02; Z-score: 3.65E-01 | ||
Methylation in Case |
4.21E-02 (Median) | Methylation in Control | 2.92E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC27A3 in breast cancer | [ 3 ] | |||
Location |
Body (cg15930240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 5.67E-09; Z-score: 1.84E+00 | ||
Methylation in Case |
7.00E-01 (Median) | Methylation in Control | 5.63E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.64E+00 | Statistic Test | p-value: 4.48E-05; Z-score: 1.13E+00 | ||
Methylation in Case |
1.92E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 9.50E-03; Z-score: 7.34E-01 | ||
Methylation in Case |
7.80E-01 (Median) | Methylation in Control | 7.56E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.86E+00 | Statistic Test | p-value: 5.43E-06; Z-score: 1.46E+00 | ||
Methylation in Case |
2.61E-01 (Median) | Methylation in Control | 1.40E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.93E+00 | Statistic Test | p-value: 3.40E-04; Z-score: 1.03E+00 | ||
Methylation in Case |
1.56E-01 (Median) | Methylation in Control | 8.08E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.01E-02; Z-score: -4.39E-01 | ||
Methylation in Case |
9.33E-01 (Median) | Methylation in Control | 9.41E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
1stExon (cg06089988) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 5.34E-05; Z-score: 1.54E+00 | ||
Methylation in Case |
9.60E-02 (Median) | Methylation in Control | 7.86E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
1stExon (cg07246449) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 1.60E-04; Z-score: 1.19E+00 | ||
Methylation in Case |
8.15E-02 (Median) | Methylation in Control | 7.10E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
1stExon (cg23376526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 9.81E-04; Z-score: 1.15E+00 | ||
Methylation in Case |
9.70E-02 (Median) | Methylation in Control | 8.10E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in colorectal cancer | [ 5 ] | |||
Location |
3'UTR (cg11804721) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 1.58E-03; Z-score: -1.07E+00 | ||
Methylation in Case |
6.35E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 5.17E-08; Z-score: -1.17E+00 | ||
Methylation in Case |
8.26E-01 (Median) | Methylation in Control | 8.49E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 2.02E-07; Z-score: 1.50E+00 | ||
Methylation in Case |
7.77E-01 (Median) | Methylation in Control | 7.12E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 1.04E-06; Z-score: -1.26E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 2.23E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.16E-05; Z-score: -1.10E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 7.38E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 1.22E-08; Z-score: -1.36E+00 | ||
Methylation in Case |
1.95E-01 (Median) | Methylation in Control | 2.82E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.66E+00 | Statistic Test | p-value: 1.21E-06; Z-score: -1.22E+00 | ||
Methylation in Case |
1.11E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 9.56E-04; Z-score: -7.91E-01 | ||
Methylation in Case |
1.29E-01 (Median) | Methylation in Control | 1.69E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.36E+00 | Statistic Test | p-value: 1.39E-02; Z-score: -6.80E-01 | ||
Methylation in Case |
5.53E-02 (Median) | Methylation in Control | 7.50E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg01841415) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 2.09E-18; Z-score: -5.43E+00 | ||
Methylation in Case |
4.81E-01 (Median) | Methylation in Control | 6.93E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg03364832) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.74E+00 | Statistic Test | p-value: 4.31E-18; Z-score: -3.80E+00 | ||
Methylation in Case |
3.79E-01 (Median) | Methylation in Control | 6.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg22985016) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.94E+00 | Statistic Test | p-value: 1.53E-17; Z-score: -2.95E+00 | ||
Methylation in Case |
3.69E-01 (Median) | Methylation in Control | 7.17E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg25368728) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 2.88E-14; Z-score: -2.92E+00 | ||
Methylation in Case |
5.11E-01 (Median) | Methylation in Control | 7.20E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg00502885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 1.33E-11; Z-score: -4.09E+00 | ||
Methylation in Case |
5.66E-01 (Median) | Methylation in Control | 7.84E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg23701033) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 6.16E-10; Z-score: -1.88E+00 | ||
Methylation in Case |
3.67E-01 (Median) | Methylation in Control | 4.94E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 15 |
Methylation of SLC27A3 in hepatocellular carcinoma | [ 6 ] | |||
Location |
3'UTR (cg16392193) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.51E+00 | Statistic Test | p-value: 1.92E-17; Z-score: -3.83E+00 | ||
Methylation in Case |
2.72E-01 (Median) | Methylation in Control | 4.12E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 2.82E-04; Z-score: 2.10E+00 | ||
Methylation in Case |
7.08E-01 (Median) | Methylation in Control | 6.08E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 3.82E-03; Z-score: 2.53E+00 | ||
Methylation in Case |
3.74E-01 (Median) | Methylation in Control | 2.78E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 1.36E-02; Z-score: 1.01E+00 | ||
Methylation in Case |
7.88E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.55E+00 | Statistic Test | p-value: 4.21E-05; Z-score: 2.50E+00 | ||
Methylation in Case |
1.39E-01 (Median) | Methylation in Control | 8.95E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg24408896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 4.27E-03; Z-score: 2.26E+00 | ||
Methylation in Case |
3.28E-01 (Median) | Methylation in Control | 2.31E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 5.20E-03; Z-score: 1.59E+00 | ||
Methylation in Case |
4.11E-01 (Median) | Methylation in Control | 3.27E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 5.30E-03; Z-score: 1.60E+00 | ||
Methylation in Case |
3.16E-01 (Median) | Methylation in Control | 2.37E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg05784314) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.28E+00 | Statistic Test | p-value: 2.90E-02; Z-score: 2.64E+00 | ||
Methylation in Case |
1.00E-01 (Median) | Methylation in Control | 7.82E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC27A3 in lung adenocarcinoma | [ 7 ] | |||
Location |
Body (cg15930240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 4.50E-02; Z-score: 2.87E+00 | ||
Methylation in Case |
7.85E-01 (Median) | Methylation in Control | 7.02E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg07748193) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.44E-02; Z-score: -4.65E-01 | ||
Methylation in Case |
5.59E-01 (Median) | Methylation in Control | 5.69E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg04590638) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.31E+00 | Statistic Test | p-value: 3.81E-28; Z-score: -3.74E+00 | ||
Methylation in Case |
5.47E-01 (Median) | Methylation in Control | 7.16E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg15164708) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.25E+00 | Statistic Test | p-value: 3.87E-23; Z-score: 3.18E+00 | ||
Methylation in Case |
5.08E-01 (Median) | Methylation in Control | 4.06E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg04310063) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 2.48E-11; Z-score: -1.55E+00 | ||
Methylation in Case |
7.18E-01 (Median) | Methylation in Control | 7.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg07566700) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 5.04E-10; Z-score: -1.56E+00 | ||
Methylation in Case |
7.56E-01 (Median) | Methylation in Control | 8.19E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg14673267) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.46E-02; Z-score: 5.31E-01 | ||
Methylation in Case |
9.09E-01 (Median) | Methylation in Control | 8.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC27A3 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg07562926) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 2.74E-02; Z-score: 4.75E-01 | ||
Methylation in Case |
7.37E-01 (Median) | Methylation in Control | 7.22E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in panic disorder | [ 9 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -8.99E-01 | Statistic Test | p-value: 7.80E-03; Z-score: -3.70E-01 | ||
Methylation in Case |
-1.66E+00 (Median) | Methylation in Control | -1.49E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg03138446) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.10E-11; Z-score: 1.50E+00 | ||
Methylation in Case |
8.70E-01 (Median) | Methylation in Control | 8.22E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg26904702) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 4.53E-07; Z-score: 1.34E+00 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 7.08E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg21279955) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.22E+00 | Statistic Test | p-value: 4.44E-03; Z-score: 6.68E-01 | ||
Methylation in Case |
1.70E-01 (Median) | Methylation in Control | 1.38E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS1500 (cg00421624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 9.40E-03; Z-score: 7.45E-01 | ||
Methylation in Case |
8.00E-01 (Median) | Methylation in Control | 7.65E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS200 (cg19773045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.37E+00 | Statistic Test | p-value: 1.75E-03; Z-score: 8.45E-01 | ||
Methylation in Case |
2.01E-01 (Median) | Methylation in Control | 1.47E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS200 (cg06239526) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.63E+00 | Statistic Test | p-value: 2.14E-03; Z-score: 8.60E-01 | ||
Methylation in Case |
1.03E-01 (Median) | Methylation in Control | 6.35E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
TSS200 (cg16247817) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 3.28E-02; Z-score: 2.20E-01 | ||
Methylation in Case |
8.49E-02 (Median) | Methylation in Control | 8.08E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
1stExon (cg06089988) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 6.74E-03; Z-score: -6.84E-01 | ||
Methylation in Case |
8.25E-02 (Median) | Methylation in Control | 8.84E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
1stExon (cg18163252) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 3.73E-02; Z-score: -2.71E-01 | ||
Methylation in Case |
4.42E-02 (Median) | Methylation in Control | 4.58E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC27A3 in papillary thyroid cancer | [ 10 ] | |||
Location |
3'UTR (cg11804721) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 3.44E-12; Z-score: -1.92E+00 | ||
Methylation in Case |
4.14E-01 (Median) | Methylation in Control | 5.53E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg23968154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.35E+00 | Statistic Test | p-value: 4.37E-06; Z-score: -2.09E+00 | ||
Methylation in Case |
4.94E-01 (Median) | Methylation in Control | 6.65E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg17805836) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 1.98E-05; Z-score: -4.34E+00 | ||
Methylation in Case |
7.82E-01 (Median) | Methylation in Control | 8.83E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg17298751) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 8.23E-05; Z-score: 1.22E+00 | ||
Methylation in Case |
7.50E-01 (Median) | Methylation in Control | 6.77E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC27A3 in colon adenocarcinoma | [ 11 ] | |||
Location |
Body (cg12082025) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.38E+00 | Statistic Test | p-value: 1.45E-03; Z-score: -1.53E+00 | ||
Methylation in Case |
5.71E-01 (Median) | Methylation in Control | 7.87E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.